Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions

Ohmyungsamycins (OMSs) A and B are cyclic depsipeptides produced by marine Streptomyces strains, which are synthesized by a non-ribosomal peptide synthetase. Notably, OMS A exhibits more potent activity against Mycobacterium tuberculosis and human cancer cells than OMS B. The substrate promiscuous a...

Full description

Bibliographic Details
Main Authors: Eunji Kim, Young Eun Du, Yeon Hee Ban, Yern-Hyerk Shin, Dong-Chan Oh, Yeo Joon Yoon
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.626881/full
_version_ 1818949969925636096
author Eunji Kim
Young Eun Du
Yeon Hee Ban
Yern-Hyerk Shin
Dong-Chan Oh
Yeo Joon Yoon
author_facet Eunji Kim
Young Eun Du
Yeon Hee Ban
Yern-Hyerk Shin
Dong-Chan Oh
Yeo Joon Yoon
author_sort Eunji Kim
collection DOAJ
description Ohmyungsamycins (OMSs) A and B are cyclic depsipeptides produced by marine Streptomyces strains, which are synthesized by a non-ribosomal peptide synthetase. Notably, OMS A exhibits more potent activity against Mycobacterium tuberculosis and human cancer cells than OMS B. The substrate promiscuous adenylation (A) domain in the second module of OMS synthetase recruits either L-Val or L-Ile to synthesize OMSs A and B, respectively. Engineering of the substrate-coding residues of this A domain increased OMS A production by 1.2-fold, coupled with a drastic decrease in OMS B production. Furthermore, the culture conditions (sea salt concentration, inoculum size, and the supply of amino acids to serve as building blocks for OMS) were optimized for OMS production in the wild-type strain. Finally, cultivation of the A2-domain-engineered strain under the optimized culture conditions resulted in up to 3.8-fold increases in OMS A yields and an 8.4-fold decrease in OMS B production compared to the wild-type strain under the initial culture conditions.
first_indexed 2024-12-20T09:11:09Z
format Article
id doaj.art-c0d7f875e1364e19961da6c18b8861d1
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-20T09:11:09Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-c0d7f875e1364e19961da6c18b8861d12022-12-21T19:45:34ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-02-011210.3389/fmicb.2021.626881626881Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture ConditionsEunji KimYoung Eun DuYeon Hee BanYern-Hyerk ShinDong-Chan OhYeo Joon Yoon0atural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South KoreaOhmyungsamycins (OMSs) A and B are cyclic depsipeptides produced by marine Streptomyces strains, which are synthesized by a non-ribosomal peptide synthetase. Notably, OMS A exhibits more potent activity against Mycobacterium tuberculosis and human cancer cells than OMS B. The substrate promiscuous adenylation (A) domain in the second module of OMS synthetase recruits either L-Val or L-Ile to synthesize OMSs A and B, respectively. Engineering of the substrate-coding residues of this A domain increased OMS A production by 1.2-fold, coupled with a drastic decrease in OMS B production. Furthermore, the culture conditions (sea salt concentration, inoculum size, and the supply of amino acids to serve as building blocks for OMS) were optimized for OMS production in the wild-type strain. Finally, cultivation of the A2-domain-engineered strain under the optimized culture conditions resulted in up to 3.8-fold increases in OMS A yields and an 8.4-fold decrease in OMS B production compared to the wild-type strain under the initial culture conditions.https://www.frontiersin.org/articles/10.3389/fmicb.2021.626881/fullohmyungsamycinnon-ribosomal peptide synthetaseadenylation domain engineeringsite-directed mutagenesisculture condition optimization
spellingShingle Eunji Kim
Young Eun Du
Yeon Hee Ban
Yern-Hyerk Shin
Dong-Chan Oh
Yeo Joon Yoon
Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
Frontiers in Microbiology
ohmyungsamycin
non-ribosomal peptide synthetase
adenylation domain engineering
site-directed mutagenesis
culture condition optimization
title Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
title_full Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
title_fullStr Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
title_full_unstemmed Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
title_short Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
title_sort enhanced ohmyungsamycin a production via adenylation domain engineering and optimization of culture conditions
topic ohmyungsamycin
non-ribosomal peptide synthetase
adenylation domain engineering
site-directed mutagenesis
culture condition optimization
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.626881/full
work_keys_str_mv AT eunjikim enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions
AT youngeundu enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions
AT yeonheeban enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions
AT yernhyerkshin enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions
AT dongchanoh enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions
AT yeojoonyoon enhancedohmyungsamycinaproductionviaadenylationdomainengineeringandoptimizationofcultureconditions